human t cells Search Results


96
ATCC tzm bl arp 8129 reporter cell lines
Tzm Bl Arp 8129 Reporter Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tzm bl arp 8129 reporter cell lines/product/ATCC
Average 96 stars, based on 1 article reviews
tzm bl arp 8129 reporter cell lines - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

90
Celprogen Inc primary human t lymphocytes
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Primary Human T Lymphocytes, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human t lymphocytes/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
primary human t lymphocytes - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Cedarlane human t cell immunocolumns
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Cell Immunocolumns, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell immunocolumns/product/Cedarlane
Average 90 stars, based on 1 article reviews
human t cell immunocolumns - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

93
Cedarlane human t cell recovery column kit
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Cell Recovery Column Kit, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell recovery column kit/product/Cedarlane
Average 93 stars, based on 1 article reviews
human t cell recovery column kit - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

91
Cell Signaling Technology Inc cell signal 28
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Cell Signal 28, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell signal 28/product/Cell Signaling Technology Inc
Average 91 stars, based on 1 article reviews
cell signal 28 - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

91
R&D Systems human t cell base media
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Cell Base Media, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell base media/product/R&D Systems
Average 91 stars, based on 1 article reviews
human t cell base media - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

92
R&D Systems human rhabdomyosarcoma cell line
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human Rhabdomyosarcoma Cell Line, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human rhabdomyosarcoma cell line/product/R&D Systems
Average 92 stars, based on 1 article reviews
human rhabdomyosarcoma cell line - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

92
R&D Systems human cell cultures
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human Cell Cultures, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cell cultures/product/R&D Systems
Average 92 stars, based on 1 article reviews
human cell cultures - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

99
Thermo Fisher dynabeads cd3 cd28 t cell expander
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Dynabeads Cd3 Cd28 T Cell Expander, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dynabeads cd3 cd28 t cell expander/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
dynabeads cd3 cd28 t cell expander - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

90
OriGene human jurkat t cell cdna library
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human Jurkat T Cell Cdna Library, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human jurkat t cell cdna library/product/OriGene
Average 90 stars, based on 1 article reviews
human jurkat t cell cdna library - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

98
Thermo Fisher cd3 cd28 dynabeads
(A) Tfh gene expression by naïve and memory Th cells (from three donors) activated with <t>anti-CD3</t> and <t>anti-CD28</t> in the presence or absence of sOX40L for 48 h. Transcript counts in the cultured Th cells are shown after normalization to housekeeping genes. Mean ± s.d., n=3. Paired t-test. * p <0.05, ** p <0.01.
Cd3 Cd28 Dynabeads, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd3 cd28 dynabeads/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
cd3 cd28 dynabeads - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

94
fluidigm maxpar human t cell phenotyping panel kit
(A) Tfh gene expression by naïve and memory Th cells (from three donors) activated with <t>anti-CD3</t> and <t>anti-CD28</t> in the presence or absence of sOX40L for 48 h. Transcript counts in the cultured Th cells are shown after normalization to housekeeping genes. Mean ± s.d., n=3. Paired t-test. * p <0.05, ** p <0.01.
Maxpar Human T Cell Phenotyping Panel Kit, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/maxpar human t cell phenotyping panel kit/product/fluidigm
Average 94 stars, based on 1 article reviews
maxpar human t cell phenotyping panel kit - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

Image Search Results


Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary human T lymphocyte-derived serum-free CM, respectively.

Journal: Genes & Diseases

Article Title: Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes

doi: 10.1016/j.gendis.2022.08.007

Figure Lengend Snippet: Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary human T lymphocyte-derived serum-free CM, respectively.

Article Snippet: Primary human T lymphocytes (#33002-02, Celprogen, CA, USA) were cultured in CTS™ OpTmizer™ T-Cell Expansion SFM (#A3705001, Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Derivative Assay

(A) Tfh gene expression by naïve and memory Th cells (from three donors) activated with anti-CD3 and anti-CD28 in the presence or absence of sOX40L for 48 h. Transcript counts in the cultured Th cells are shown after normalization to housekeeping genes. Mean ± s.d., n=3. Paired t-test. * p <0.05, ** p <0.01.

Journal: Immunity

Article Title: OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T follicular Helper Response

doi: 10.1016/j.immuni.2015.05.012

Figure Lengend Snippet: (A) Tfh gene expression by naïve and memory Th cells (from three donors) activated with anti-CD3 and anti-CD28 in the presence or absence of sOX40L for 48 h. Transcript counts in the cultured Th cells are shown after normalization to housekeeping genes. Mean ± s.d., n=3. Paired t-test. * p <0.05, ** p <0.01.

Article Snippet: Th cells were stimulated overnight with CD3/CD28 Dynabeads (Invitrogen) in RPMI complete medium supplemented with 10% FCS.

Techniques: Expressing, Cell Culture

(A) Expression of CXCR5, IL-21, CD40L, Bcl-6, and T-bet by naïve and memory Th cells activated with anti-CD3 and anti-CD28 in the presence or absence of sOX40L and/or IL-12. Gated to FSChiSSChi activated cells. A representative result out of 3 independent experiments is shown.

Journal: Immunity

Article Title: OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T follicular Helper Response

doi: 10.1016/j.immuni.2015.05.012

Figure Lengend Snippet: (A) Expression of CXCR5, IL-21, CD40L, Bcl-6, and T-bet by naïve and memory Th cells activated with anti-CD3 and anti-CD28 in the presence or absence of sOX40L and/or IL-12. Gated to FSChiSSChi activated cells. A representative result out of 3 independent experiments is shown.

Article Snippet: Th cells were stimulated overnight with CD3/CD28 Dynabeads (Invitrogen) in RPMI complete medium supplemented with 10% FCS.

Techniques: Expressing

(A) Bcl-6 expression by naïve Th cells transfected with the indicated siRNA and cultured for 3 days with anti-CD3 and CD28 ± sOX40L. Gated to FSChiSSChi activated cells. Mean ± s.e.m., n=3.

Journal: Immunity

Article Title: OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T follicular Helper Response

doi: 10.1016/j.immuni.2015.05.012

Figure Lengend Snippet: (A) Bcl-6 expression by naïve Th cells transfected with the indicated siRNA and cultured for 3 days with anti-CD3 and CD28 ± sOX40L. Gated to FSChiSSChi activated cells. Mean ± s.e.m., n=3.

Article Snippet: Th cells were stimulated overnight with CD3/CD28 Dynabeads (Invitrogen) in RPMI complete medium supplemented with 10% FCS.

Techniques: Expressing, Transfection, Cell Culture